SCHEMBL12619862

SCHEMBL12619862

C=C(C)CN(Cc1ccccc1)[C@@H](CO)C(=O)OCc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
EPOR P19235 1/20 0.39
ALOX5 P09917 1/20 0.39
PTGS1 P23219 1/20 0.39
PTGS2 P35354 1/20 0.39
EGFR P00533 2/20 0.38
KMT2A Q03164 3/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
MAPK1 P28482 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A3 Q01959 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
ELANE P08246 1/20 0.38
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
LMNA P02545 4/20 0.37
MEN1 O00255 1/20 0.37
POLB P06746 1/20 0.36
HSD17B10 Q99714 1/20 0.36
FKBP1A P62942 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15448254 0.86 ALDH1A1 (0.47) ALDH1A1EPORKMT2AL3MBTL1MAPK1
SCHEMBL10315706 0.86 ALDH1A1 (0.47) ALDH1A1EPORKMT2AL3MBTL1MAPK1
SCHEMBL12799366 0.86 ALDH1A1 (0.47) ALDH1A1EPORKMT2AL3MBTL1MAPK1
SCHEMBL12653377 0.85 TSHR (0.41) ALDH1A1EPORKMT2AL3MBTL1MAPK1
SCHEMBL824998 0.79 ALDH1A1 (0.50) ALDH1A1KMT2AL3MBTL1MAPK1SLC6A2
SCHEMBL634623 0.79 ALDH1A1 (0.50) ALDH1A1KMT2AL3MBTL1MAPK1SLC6A2
SCHEMBL18085351 0.77 ALDH1A1 (0.51) ALDH1A1EPORALOX5PTGS1PTGS2
SCHEMBL12282608 0.77 ALDH1A1 (0.39) ALDH1A1EPORALOX5PTGS1PTGS2
SCHEMBL16405273 0.77 ALDH1A1 (0.39) ALDH1A1EPORKMT2AL3MBTL1MAPK1
SCHEMBL12282611 0.77 ALDH1A1 (0.39) ALDH1A1EPORKMT2AL3MBTL1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7951801-B2 For therapy of inflammatory disease and cancer MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-05-31 US disclosed
US-7727985-B2 Beta-carbolines useful for treating inflammatory disease MILLENNIUM PHARMACEUTICALS, INC. (US) 2010-06-01 US disclosed
US-20100093713-A1 BETA-CARBOLINES USEFUL FOR TREATING INFLAMMATORY DISEASE MILLENNIUM PHARMACEUTICALS, INC. (US) 2010-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100093713-A1 BETA-CARBOLINES USEFUL FOR TREATING INFLAMMATORY DISEASE NFKBIA, NFKB2, IKBKG ALDH1A1 3426/4885EPOR 3304/4885ALOX5 2178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.